It provides a robust immune boost, supports tissue repair, and accelerates healing processes
Tropea A, Miceli F, Minici F, Tiberi F, Orlando M, Gangale MF, Romani F, Catino S, Mancuso S, Navarra P, et al: Regulation of vascular endothelial growth factor synthesis and release by human luteal cells in vitro
It has completed Phase 3 clinical trials (the REDEFINE program) with positive results, and Novo Nordisk is expected to seek FDA approval
Half of those are likely NOD candidates with 1% of NOD individuals at a higher risk for PDAC diagnosis ( Figure 1B ) ( Figure 1 Although it is well established that a small proportion of patients with NOD have an increased risk of subsequently being diagnosed with PDAC, translating this association into a broadly applicable clinical strategy remains challenging
Dutta NK, Bruiners N, Zimmerman MD, Tan S, Dartois V, Gennaro ML, Karakousis PC
Despite claims on social media of its efficacy, no human trial to date has shown it to be effective at repairing muscle or improving performance in healthy individuals